Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells

Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells

US Patent 8263065 · Granted Sep 11, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for improving quality of life and increasing activity i2025
Rapid detection method for abrin toxin2025
Rapid detection method for ricin toxin2025
Spray dried follistatin product2025
Methods for alleviating, inhibiting or reversing muscle disuse atrophy in mammal2025
Method for generating three-dimensional images with superconducting nanowire pho2024
Methods and compositions for improving quality of life and increasing activity i2023
Methods for the quantitation of polypeptides2023
Treatment of inflammatory diseases using placental stem cells2023
Enhanced placental stem cells and uses thereof2022
Enhanced placental stem cells and uses thereof2022
Methods and compositions for improving skeletal muscle protein fractional synthe2022